Dr. Randeep Singh

Head of Department (HOD)

28 Years of Experience

Medical Oncologist

MBBS, MD, DM, FCCP

Reg. No.:32096, Delhi Medical Council

Dharamshila Narayana Superspeciality Hospital, New Delhi

English, Hindi, Punjabi

Consultation Fee ₹ 2000

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Randeep Singh

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

About Dr. Randeep Singh

Dr. Randeep Singh is a renowned and experienced medical oncologist in Delhi with an impressive experience of 28 years.
He is trained and well-versed in dealing with solid and hematolymphoid tumors. He also specializes in different types of chemotherapy while providing precision oncology-based treatment.
Dr. Randeep Singh has vast experience with patients affected with cancer in the lungs, blood, breast, gastrointestinal tract, liver, pancreas, bile duct, and genitourinary tract.
He has expertise in offering cancerous treatments like
- Target Therapy
- Immunotherapy
- Hormone Therapy
- Biotherapy
- Precision Oncology
Dr. Randeep Singh did an MBBS from Bharati Vidyapeeth Deemed University in 1996, and his specialization was DM in Medical Oncology at Tata Memorial Centre in 2008.
He also earned an MD in Pediatrics from S.N. Medical College, Jodhpur, Rajasthan University, in 2003.
Dr. Singh has been certified by the European Certified Medical Oncology (ECMO) and is a Fellow American Chest Physicians (FCCP).
He has been an active participant in quizzes where he won first and second positions. Further, he has multiple published papers.
Dr. Singh is associated with numerous organizations and is editor-in-chief of research journals.

Confirm Your Consultation With Dr. Randeep Singh

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS - Bharati Vidyapeeth Deemed University, 1996
MD - Pediatrics - S.N. Medical College, Jodhpur, Rajasthan University, 2003
DM - Medical Oncology - Tata Memorial Centre, 2008
Fellow American Chest Physicians (FCCP)

Training & Certificates

European Certified Medical Oncology (ECMO)

OPD Schedule Of Dr. Randeep Singh

Book Appointment

Past Experience

Senior Consultant and Unit Head Medical Oncology at Artemis Hospital, Gururgram
Department of Medical Oncology at HCG Cancer Center, Delhi
Consultant Medical Oncologist at Max Group of Hospitals, Patparganj, 2015
Consultant Medical Oncologist at Tata Memorial Hospital, Mumbai, 2012
Senior Resident in Tata Memorial Hospital, 2011
Senior Residency in Pediatrics at PGIMER, Chandigarh

Second Position in Geriatric Oncology Case presentation from the Indian Cooperative Oncology Network in 2014
Second Position in Hematology Quiz at the National Level from Mumbai Hematology Group in 2011
First Position in Neonatology quiz at State Level from National Neonatology in 2006
First Position in Post-Graduate Quiz from Indian Academy Pediatrics at the State Level in 2006
Second Position in Paper Presentation from Indian Academy Pediatrics at State Levels in 2006
Received Distinction in Biochemistry, Surgery, and Ophthalmology from BVDU, Pune, during MBBS in 2000

Parikh, P., Babu, G., Singh, R., Krishna, V., Bhatt, A., Bansal, I., ... & Rath, G. K. (2023). Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method. BMC cancer, 23(1), 714.
Parikh, P. M., & Singh, R. (2020). Why should we rely only on molecular tests based on Indian data? Int J Mol Immuno Oncol, 5, 44-46.
Parikh, P., & Singh, R. (2021). Hot race for COVID-19 vaccines–light at the end of the tunnel just got brighter. International Journal of Molecular and Immuno Oncology, 6(1), 1-3.
Parikh, P., Kapoor, A., Joshi, K., Bansal, I., Krishna, V., Sahoo, T. P., ... & Babu, K. G. (2021). Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian Association for Regional Cooperation Region. International Journal of Molecular & Immuno Oncology, 6(2), 61–65.
Singh, R., & Gupta, S. (2018). Small HER2 positive breast cancer: When is enough? Indian Journal of Medical and Paediatric Oncology, 39(01), 1–3.
Singh, R., & Rohtagi, N. (2017). Clinicopathological and molecular epidemiological study of lung cancer patients seen at a tertiary care hospital in Northern India. South Asian Journal of Cancer, 6(04), 171-175.
Singh, R., Shirali, R., Chatterjee, S., Adhana, A., & Arora, R. S. (2016). Epidemiology of cancers among adolescents and young adults from a tertiary cancer center in Delhi. Indian Journal of Medical and Paediatric Oncology, 37(02), 90–94.